首页> 外文会议>International forum on post-genome technologies >DIFFERENTIAL EXPRESSION OF HUMAN TELOMERASE REVERSE TRANSCRIFIASE β-SITE REMAINING LTERNATIVE SPLCING VARIANTS (HTERT β+ ASV) IN GASTRIC CANCER AND PRECANCEROUS LESIONS
【24h】

DIFFERENTIAL EXPRESSION OF HUMAN TELOMERASE REVERSE TRANSCRIFIASE β-SITE REMAINING LTERNATIVE SPLCING VARIANTS (HTERT β+ ASV) IN GASTRIC CANCER AND PRECANCEROUS LESIONS

机译:人端粒酶逆转录酶β位差异表达含有胃癌和癌前病变的替代剪接变体(HTERTβ+ ASV)

获取原文

摘要

Objective:To investigate the changes of hTERT alternative splicing variants pattern in gastric cancer, precancerous lesions and normal gastric mucosa tissue. Methods: Three alternative splicing sites (α, β, γ) were selected using Semi-nested RT-PCR and SYBER Green real-time PCR. Telomerase enzyme activity was evaluated associated with the different hTERT ASVs. Results: The positive rates of β+ ASVs were 11. 1% in normal mucosa, 40. 0% in precancerous lesions and 94. 7% in gastric cancer (P<0. 05). SYBR Green real-time RT-PCR showed that the expression level of β + ASV was 6. 99 times higher in gastric cancer than in precancerous lesions. Further, increased telomerase enzyme activity was only associated with expression of the full-length hTERT isoform. Conclusion: The gene expression patterns of hTERT alternative splicing variants may provide some useful information for diagnosis of gastric cancer and precancerous lesions.
机译:目的:探讨胃癌,癌前病变和正常胃黏膜组织HTERT替代拼接变体模式的变化。方法:使用半嵌套RT-PCR和Syber绿色实时PCR选择三个替代剪接位点(α,β,γ)。评估端粒酶酶活性与不同的HTERT ASV相关。结果:β+ ASVs的阳性率在正常粘膜中为11.1%,癌前病变中的40.0%,94.胃癌中的7%(P <0.05)。 SYBR绿色实时RT-PCR显示β+ ASV的表达水平为胃癌患者比癌前病变高99倍。此外,增加的端粒酶酶活性仅与全长HTERT同种型的表达相关。结论:HTERT替代剪接变体的基因表达模式可以提供一些有用的信息,用于诊断胃癌和癌前病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号